LPKF LASER+ELECTR.INH ON overview

EQS-News: LPKF Laser & Electronics SE / Key word(s): Personnel LPKF extends contract of CEO Klaus Fiedler until 2028 23.04.2024 / 18:44 CET/CEST The issuer is solely responsible for the content of this announcement. Garbsen, April 23, 2024 – The Supervisory Board of LPKF Laser & Electronics SE has decided to extend the contract of Dr. Klaus Fiedler as CEO until 31 December 2028. "Under the leadership of Klaus Fiedler, LPKF has undergone some extensive transformation since he joined just over 2...

EQS-News: LPKF Laser & Electronics SE / Key word(s): Annual Report LPKF reports strategic successes and narrowly achieves forecast for 2023 financial year 21.03.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Garbsen, 21 March 2024 – LPKF Laser & Electronics SE generated revenue of EUR 124.3 million in the financial year (previous year: EUR 123.7 million) and earnings before interest and tax (EBIT) of EUR 3.7 million (previous year: EUR 6.8...

EQS-News: LPKF Laser & Electronics SE / Key word(s): Incoming Orders LPKF receives major customer order in solar 18.03.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Garbsen, March 18th, 2024 - The technology company LPKF Laser & Electronics SE has once again received a major order in the solar market, continuing its long-standing successful collaboration with a leading international manufacturer. As part of this order LPKF will supply high-precision...

EQS-Media / 05.02.2024 / 14:00 CET/CEST Garbsen, Germany, (February 5 th 2024). ARRALYZE®, the Life Science arm of LPKF Laser & Electronics SE, proudly announces the commercial availability of the CellShepherd®. After a successful beta-testing phase in 2023, this groundbreaking platform is now ready to revolutionize cell-based research and development across biomedical and various life science fields. CellShepherd®: Redefining Single-Cell Analysis CellShepherd®, developed by ARRALYZE®,...

EQS-News: LPKF Laser & Electronics SE / Key word(s): 9 Month figures LPKF: Business development in the third quarter gains significant momentum 26.10.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Sales and Earnings of third quarter at upper end of the forecast Order book plus 56 % and incoming orders plus 29 % year-on-year Management Board confirms full-year forecast and remains confident for the coming years Garbsen, 26.10.2023 - The business...

EQS-News: LPKF Laser & Electronics SE / Key word(s): Half Year Report LPKF remains on track in the first half of 2023 27.07.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. LPKF remains on track in the first half of 2023 Second quarter revenue and earnings in line with forecast Order backlog up 48%, order intake up 38% Management Board refines full-year guidance and remains confident about subsequent years Garbsen, Germany, July 27, 2023 - LPKF Laser &...

EQS-Media / 12.07.2023 / 11:12 CET/CEST Garbsen, July 12, 2023 -The technology company LPKF Laser & Electronics SE and its new biotechnology division ARRALYZE will move into the BioLabs Group's renowned co-working spaces in Boston, USA, this July. BioLabs helps startups bring breakthrough new ideas and technologies to Life-Science markets. In doing so, BioLabs selects only innovations that have the potential to advance the life sciences and make a tangible contribution to improving medical care....